Clinical Trials Logo

Clinical Trial Summary

Comparison of trichloroacetic acid versus cantharidine for the treatment of perenial warts.


Clinical Trial Description

Warts are one of the most common sexually transmitted diseases. They are caused by the human papilloma virus (HPV) that causes cervical cancer. Warts can grow, obstruct labor, and spread. Patients presenting to the obgyn clinic with perenial warts were randomized to treatment with trichloroacetic acid (one of the many types of treatments) or to the treatment with cantharidine group. Cantharidine is a vesicant extracted from beetle bugs which painlessly causes a small blister to form and cures the patient from the HPV infection causing the wart . We compared cosmesis, scar formation, pain and number of treatments (visits) as well as effectiveness in both groups.

Objectives

1. Determine if cantharone is more effective than trichloroacetic acid (TCA) for removal of warts

2. Compare pain levels (pain during application) for each method

3. Compare patient satisfaction for each method

4. Compare scar formation and cosmesis for each method ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03625960
Study type Interventional
Source Wayne State University
Contact
Status Completed
Phase Phase 4
Start date June 15, 2006
Completion date July 15, 2007

See also
  Status Clinical Trial Phase
Completed NCT05100043 - Interleukin 4 and Interferon Gamma Predictors of Human Papillomavirus Immunotherapy in Warts